Medpace Holdings, Inc. — Director's Dealing 2021

Apr 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-04-27

Reporting Person: Troendle August J. (Director, President & CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-27	Employee Stock Option (Right to Buy)	$166.73	A	57570	Acquired	2029-04-27	Common Stock (57570)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6319992	Indirect
Common Stock	706643	Direct

Footnotes

F1: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F2: The Option vests on April 27, 2023, subject to the Reporting Person's continued employment with the Issuer.